Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Causal role of blood metabolites in HER-positive and HER-negative breast cancer: a Mendelian randomization (MR) study.

Aging - 2 Aug 2024

Yue Jian, Fang Huiying, Chen Sheng, Gu Lei, Ren Guosheng

Abstract excerpt

BACKGROUND: Previous studies provide evidence that in vivo metabolites are associated with breast cancer (BC). However, the causal relationship between blood metabolites and BC remains unclear. METHOD: Comprehensive two-sample Mendelian randomization analysis was conducted to determine the causal association between 1400 publicly available genetic data on metabolic factors and human epidermal growth factor...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Erb-b2 Receptor Tyrosine Kinases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to GPI gene

Share to Mendelian Randomization Analysis

Share to Polymorphism, Single Nucleotide

Source

Open in PubMed Open full text

Identifiers

PMID: 39103210
DOI: 10.18632/aging.206042
PMCID: PMC11346783

Genes

GPI

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Causal role of blood metabolites in HER-positive and HER-negative breast cancer: a Mendelian randomization (MR) study.PMID 39103210Read ↗

Causal plasma metabolites for breast cancer risk: a two-sample Mendelian randomization study with colocalization evidenceSemantic proximity Read ↗

Association between human blood metabolome and the risk of breast cancer.Semantic proximity Read ↗

The causal role of plasma metabolites in breast cancer susceptibility mediated by immune cells: A two-sample Mendelian randomization analysis.Semantic proximity Read ↗

Genetically predicted 486 blood metabolites in relation to risk of colorectal cancer: A Mendelian randomization study.Semantic proximity Read ↗

Causal relationship between genetically determined plasma metabolites and skin cancer: a two-sample Mendelian randomization study.Semantic proximity Read ↗

Causal association between 637 human metabolites and ovarian cancer: a mendelian randomization studySemantic proximity Read ↗

Causal inference study of the effect of serum enzymes on breast cancer risk: Two-sample Mendelian randomization.Semantic proximity Read ↗

Causal insights into immune cell profiles, plasma metabolites, and bladder cancer: A Mendelian randomization approach.Semantic proximity Read ↗

Exploring blood metabolites and thyroid disorders: a bidirectional mendelian randomization studySemantic proximity Read ↗

Circulating amino acids, amino acid metabolites, dipeptides, and other cationic metabolites and risk of breast cancerSemantic proximity Read ↗

Causal links of human serum metabolites on the risk of prostate cancer: insights from genome-wide Mendelian randomization, single-cell RNA sequencing, and metabolic pathway analysis.Semantic proximity Read ↗

Metabolomics-enabled biomarker discovery in breast cancer researchSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.